Şirket hakkında

MetaStat is focused on developing and commercializing novel diagnostic technologies and therapeutics for the early and reliable prediction and treatment of systemic metastasis, a cancer that spreads from a primary tumor through the bloodstream to other areas of the body. The company also develops a prognostic diagnostic program which is focused on developing diagnostic tests that predict the risk of future metastasis in cancer patients following the initial treatment of their primary tumor.

US
Bilinmeyen
Doğrulanmamış şirket